A1 Refereed original research article in a scientific journal

Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus




AuthorsStenholm T, Hakanen A, Salmenlinna S, Pihlasalo S, Härmä H, Hänninen P, Huovinen P, Vuopio J, Kotilainen P

Publication year2011

JournalEuropean Journal of Clinical Microbiology and Infectious Diseases

Journal name in sourceEuropean Journal of Clinical Microbiology and Infectious Diseases

Number in series10

Volume30

Issue10

First page 1237

Last page1243

Number of pages7

ISSN0934-9723

DOIhttps://doi.org/10.1007/s10096-011-1218-x


Abstract
The aim of this study was to evaluate a new type of assay for the phenotypic detection of methicillin-resistant Staphylococcus aureus (MRSA). The assay is based on a point-of-care compatible two-photon excitation fluorescence detection technology (TPX). A collection of 243 epidemic MRSA isolates was tested in addition to 138 sporadic MRSA and 101 negative control strains. The assay proved to be both sensitive (97.9%) and specific (94.1%) in the identification of MRSA, with adequate positive (98.4%) and negative (92.2%) predictive values. The time required for obtaining a positive test result was less than 14 h for 99.0% of the MRSA true-positive samples. After a test run, the selectively enriched reaction mixtures may be recovered and further studied by molecular or standard phenotypic methods. The main benefits of the TPX methodology include a simple assay procedure, low reagent consumption, and a high-throughput capacity. © 2011 Springer-Verlag.



Last updated on 2024-26-11 at 23:30